| Financial Year |
March 31 2023 |
| Monetary Funds |
1,246,748,293.50 |
| Held-for-trading Financial Assets |
391,682,179.84 |
| Notes Receivable |
63,040,696.77 |
| Accounts Receivable |
7,265,276.80 |
| Advances to Suppliers |
4,364,052.45 |
| Other Receivables |
413,772.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
66,004,014.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,134,266.48 |
| Total Current Assets |
1,814,987,210.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
112,620,436.24 |
| Under-construction Projects |
234,860,929.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,208,196.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,847,739.07 |
| Deferred Income Tax Assets |
1,417,152.87 |
| Other Non-Current Assets |
34,823,107.13 |
| Sub-Total of Non-Current Assets |
414,044,623.50 |
| Total Assets |
2,229,031,833.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,690,860.00 |
| Accounts Payable |
18,532,679.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,361,222.72 |
| Taxes Payable |
7,030,955.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,397,922.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
327,534.00 |
| Other Current Liabilities |
25,300,206.04 |
| Sub-Total of Current Liabilities |
104,324,781.51 |
| Long-term Loans |
47,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,302,560.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,169,964.74 |
| Total Liabilities |
158,494,746.25 |
| Paid-In Capital(Or Share Stock) |
214,636,500.00 |
| Capital Surplus |
1,356,778,128.08 |
| Surplus Reserve |
79,148,157.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
417,706,808.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,070,537,087.35 |
| Owner's Equity（Stockholder's Equity） |
2,070,537,087.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,229,031,833.60 |
